Sio Gene Therapies’ Exit From Oxford Biomedica Parkinson’s Collaboration Leaves Hole In Commercial Prospects

Firm Loses CEO

 
• By Ayisha Sharma
  
Parkinson's disease, substantia nigra, Lewy bodies.
Parkinson's Disease Represented The Biggest Market Opportunity For The Firm, One Expert Said. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip